These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10762715)

  • 1. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients.
    Burghaus L; Schütz U; Krempel U; de Vos RA; Jansen Steur EN; Wevers A; Lindstrom J; Schröder H
    Brain Res Mol Brain Res; 2000 Mar; 76(2):385-8. PubMed ID: 10762715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein.
    Wevers A; Monteggia L; Nowacki S; Bloch W; Schütz U; Lindstrom J; Pereira EF; Eisenberg H; Giacobini E; de Vos RA; Steur EN; Maelicke A; Albuquerque EX; Schröder H
    Eur J Neurosci; 1999 Jul; 11(7):2551-65. PubMed ID: 10383644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
    Martin-Ruiz CM; Court JA; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry RH; Perry EK
    J Neurochem; 1999 Oct; 73(4):1635-40. PubMed ID: 10501210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients.
    Burghaus L; Schütz U; Krempel U; Lindstrom J; Schröder H
    Parkinsonism Relat Disord; 2003 Jun; 9(5):243-6. PubMed ID: 12781587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease.
    Engidawork E; Gulesserian T; Balic N; Cairns N; Lubec G
    J Neural Transm Suppl; 2001; (61):211-22. PubMed ID: 11771745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease.
    Guan ZZ; Zhang X; Ravid R; Nordberg A
    J Neurochem; 2000 Jan; 74(1):237-43. PubMed ID: 10617125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches.
    Wevers A; Burghaus L; Moser N; Witter B; Steinlein OK; Schütz U; Achnitz B; Krempel U; Nowacki S; Pilz K; Stoodt J; Lindstrom J; De Vos RA; Jansen Steur EN; Schröder H
    Behav Brain Res; 2000 Aug; 113(1-2):207-15. PubMed ID: 10942047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acetylcholine binding sites in Alzheimer's disease.
    Whitehouse PJ; Martino AM; Antuono PG; Lowenstein PR; Coyle JT; Price DL; Kellar KJ
    Brain Res; 1986 Apr; 371(1):146-51. PubMed ID: 3708340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
    Hellström-Lindahl E; Mousavi M; Zhang X; Ravid R; Nordberg A
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):94-103. PubMed ID: 10095081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus basalis Meynert lesions and the expression of nicotinic acetylcholine receptor proteins in the rat frontal cerebral cortex.
    Burghaus L; Schütz U; Simonnet K; Krempel U; Lindstrom J; Schröder H
    Neurosci Lett; 2001 Mar; 301(2):111-4. PubMed ID: 11248435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvalbumin-containing interneurons of the human cerebral cortex express nicotinic acetylcholine receptor proteins.
    Krenz I; Kalkan D; Wevers A; de Vos RA; Steur EN; Lindstrom J; Pilz K; Nowacki S; Schütz U; Moser N; Witter B; Schröder H
    J Chem Neuroanat; 2001 May; 21(3):239-46. PubMed ID: 11382535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against extracellular domains of α4 and α7 subunits alter the levels of nicotinic receptors in the mouse brain and affect memory: possible relevance to Alzheimer's pathology.
    Lykhmus O; Koval L; Skok M; Zouridakis M; Zisimopoulou P; Tzartos S; Tsetlin V; Granon S; Changeux JP; Komisarenko S; Cloëz-Tayarani I
    J Alzheimers Dis; 2011; 24(4):693-704. PubMed ID: 21321393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.
    Banerjee C; Nyengaard JR; Wevers A; de Vos RA; Jansen Steur EN; Lindstrom J; Pilz K; Nowacki S; Bloch W; Schröder H
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):666-72. PubMed ID: 11114264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of nicotinic beta2 and alpha4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations.
    Sparks DL; Beach TG; Lukas RJ
    Neurosci Lett; 1998 Nov; 256(3):151-4. PubMed ID: 9855362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes.
    Jones IW; Westmacott A; Chan E; Jones RW; Dineley K; O'Neill MJ; Wonnacott S
    J Mol Neurosci; 2006; 30(1-2):83-4. PubMed ID: 17192639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
    Teaktong T; Graham A; Court J; Perry R; Jaros E; Johnson M; Hall R; Perry E
    Glia; 2003 Jan; 41(2):207-11. PubMed ID: 12509811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.